IOSP - Innospec Inc.
NEXT EARNINGS:
May 6, 2026
EPS Est: $1.08
|
Rev Est: $455.5M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$115.00
DETAILS
HIGH:
$115.00
LOW:
$115.00
MEDIAN:
$115.00
CONSENSUS:
$115.00
UPSIDE:
45.02%
Market Cap:
1.96B
Volume:
262,404
Avg Volume:
224,430
52 Week Range:
70.1-105.6
Sector:
Basic Materials
Industry:
Chemicals - Specialty
Beta:
0.88
Last Dividend:
$1.71
Exchange:
NASDAQ
Country:
US
Employees:
2,450
IPO Date:
1998-05-13
EPS (TTM):
4.69
P/E Ratio:
16.33
Revenue (TTM):
1.78B
Total Assets:
1.83B
Total Debt:
89.50M
Cash & Equiv:
292.50M
Rev Growth (5Y):
8.3%
EPS Growth (5Y):
32.0%
FCF Growth (5Y):
-5.4%
ROCE:
10.6%
Debt/Equity:
0.07
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $1.50 | $1.26 | +19.0% | $455.6M | $461.8M | -1.3% |
| 2025-11-04 | $1.12 | $1.03 | +8.7% | $441.9M | $460.9M | -4.1% |
| 2025-08-05 | $1.26 | $1.17 | +7.7% | $439.7M | $449.9M | -2.3% |
| 2025-05-08 | $1.42 | $1.40 | +1.4% | $440.8M | $467.6M | -5.7% |
| 2025-02-18 | $1.41 | $1.36 | +3.7% | $466.8M | $447.4M | +4.3% |
| 2024-11-05 | $1.35 | $1.35 | 0.0% | $443.4M | $454.9M | -2.5% |
| 2024-08-06 | $1.39 | $1.37 | +1.5% | $435.0M | $480.4M | -9.5% |
| 2024-05-09 | $1.75 | $1.64 | +6.7% | $500.2M | $504.1M | -0.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.78B | 1.85B | 1.95B | 1.96B | 1.48B | 1.19B | 1.51B | 1.48B | 1.31B | 883.40M | 1.01B | 960.90M |
| Net Income | 116.60M | 35.60M | 139.10M | 133.00M | 93.10M | 28.70M | 112.20M | 85.00M | 61.80M | 81.30M | 119.50M | 84.10M |
| EPS | 4.69 | 1.43 | 5.60 | 5.37 | 3.78 | 1.17 | 4.58 | 3.48 | 2.56 | 3.39 | 4.96 | 3.45 |
| Total Assets | 1.83B | 1.73B | 1.71B | 1.60B | 1.57B | 1.40B | 1.47B | 1.47B | 1.41B | 1.18B | 1.03B | 999.90M |
| Total Debt | 89.50M | 44.90M | 45.20M | 45.30M | 35.60M | 40.80M | 92.60M | 210.90M | 224.30M | 273.30M | 136.10M | 141.60M |
| Cash & Equivalents | 292.50M | 289.20M | 203.70M | 147.10M | 141.80M | 105.30M | 75.70M | 123.10M | 90.20M | 101.90M | 136.90M | 41.60M |
| Operating Cash Flow | 138.30M | 184.50M | 207.30M | 81.70M | 93.20M | 145.90M | 161.60M | 104.90M | 82.70M | 104.50M | 117.70M | 106.30M |
| Free Cash Flow | 88.00M | 143.10M | 145.20M | 39.40M | 54.10M | 116.20M | 131.70M | 74.80M | 50.50M | 88.00M | 91.50M | 84.40M |
| FCF per Share | 3.54 | 5.74 | 5.84 | 1.59 | 2.19 | 4.73 | 5.38 | 3.07 | 2.09 | 3.67 | 3.80 | 3.46 |
| Book Value | 1.33B | 1.21B | 1.15B | 1.04B | 1.03B | 944.40M | 918.50M | 825.50M | 794.30M | 653.80M | 605.30M | 515.90M |
| Cash & ST Investments | 292.50M | 289.20M | 203.70M | 147.10M | 141.80M | 105.30M | 75.70M | 123.10M | 90.20M | 101.90M | 141.70M | 46.30M |
| ROC Equity | 0.09 | 0.03 | 0.12 | 0.13 | 0.09 | 0.03 | 0.12 | 0.10 | 0.08 | 0.12 | 0.20 | 0.16 |